BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9219622)

  • 1. Comparison of the effects of restacorin and flecainide on various cardiac transmembrane potassium currents.
    Németh M; Virág L; Varró A; Papp JG
    Acta Physiol Hung; 1996; 84(3):317-8. PubMed ID: 9219622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of restacorin on the early and delayed after depolarization in dog Purkinje fibres.
    Krassói I; Varró A; Papp JG
    Acta Physiol Hung; 1996; 84(3):299-300. PubMed ID: 9219616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of class I anti-arrhythmic drugs, cibenzoline, mexiletine and flecainide, on the delayed rectifier K+ current of guinea-pig ventricular myocytes.
    Wang DW; Kiyosue T; Sato T; Arita M
    J Mol Cell Cardiol; 1996 May; 28(5):893-903. PubMed ID: 8762029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of benzyltetrahydropalmatine on action potentials of myocardium and transmembrane K+ and Ca2+ currents in Purkinje fibers].
    Zeng WZ; Xia GJ; Yao WX; Zong XG; Jiang MX
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):314-7. PubMed ID: 2104484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue.
    Wang Z; Fermini B; Nattel S
    J Pharmacol Exp Ther; 1993 Nov; 267(2):575-81. PubMed ID: 8246130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Chinoin-103, a new antiarrhythmic drug, on the transmembrane potentials, ionic currents and contractile force in heart muscle.
    Mészáros J; Kelemen K; Markó R; Kecskeméti V; Korbonits D; Kovács G; Szegi J
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):250-67. PubMed ID: 6135400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular electrophysiological effect of terikalant in the dog heart.
    Biliczki P; Acsai K; Virág L; Tálosi L; Jost N; Biliczki A; Papp JG; Varró A
    Eur J Pharmacol; 2005 Mar; 510(3):161-6. PubMed ID: 15763239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.
    Baczkó I; El-Reyani NE; Farkas A; Virág L; Iost N; Leprán I; Mátyus P; Varró A; Papp JG
    Eur J Pharmacol; 2000 Sep; 404(1-2):181-90. PubMed ID: 10980278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of flecainide on ATP-sensitive K(+) channels in pig urethral myocytes.
    Yunoki T; Teramoto N; Naito S; Ito Y
    Br J Pharmacol; 2001 Jul; 133(5):730-8. PubMed ID: 11429398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of genistein on ATP-sensitive K+ channels in rabbit portal vein smooth muscle.
    Ogata R; Kitamura K; Ito Y; Nakano H
    Br J Pharmacol; 1997 Dec; 122(7):1395-404. PubMed ID: 9421287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of flecainide on longitudinal and transverse conduction velocities in ventricular myocardium. An experimental study].
    Ferrero A; Chorro FJ; Cánoves J; Mainar L; Blasco E; Such L
    Rev Esp Cardiol; 2007 Mar; 60(3):315-8. PubMed ID: 17394879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ropivacaine on action potential configuration and ion currents in isolated canine ventricular cardiomyocytes.
    Szabó A; Szentandrássy N; Birinyi P; Horváth B; Szabó G; Bányász T; Márton I; Magyar J; Nánási PP
    Anesthesiology; 2008 Apr; 108(4):693-702. PubMed ID: 18362602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
    Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
    Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new antiarrhythmic substance AWD 23-111 inhibits the delayed rectifier potassium current (IK) in guinea pig ventricular myocytes.
    Klapperstück M; Markwardt F
    Pharmazie; 1999 Jan; 54(1):61-8. PubMed ID: 9987799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol.
    Fiset C; Drolet B; Hamelin BA; Turgeon J
    J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the rapid component of the delayed-rectifier K+ current by therapeutic concentrations of the antispasmodic agent terodiline.
    Jones SE; Ogura T; Shuba LM; McDonald TF
    Br J Pharmacol; 1998 Nov; 125(6):1138-43. PubMed ID: 9863639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes.
    Follmer CH; Colatsky TJ
    Circulation; 1990 Jul; 82(1):289-93. PubMed ID: 2114236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes.
    Varró A; Virág L; Papp JG
    Br J Pharmacol; 1996 Mar; 117(6):1181-6. PubMed ID: 8882613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic actions of the ATP-regulated K+ current activated by pinacidil.
    Spinelli W; Sorota S; Siegal M; Hoffman BF
    Circ Res; 1991 Apr; 68(4):1127-37. PubMed ID: 2009612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.